Impact of Recent Molecular Studies on Evaluation of Ventricular Arrhythmias Dan M. Roden OriginalPaper Pages: 7 - 16
Changing Concepts of Electrophysiology Testing for Ventricular Arrhythmias Masood Akhtar OriginalPaper Pages: 17 - 19
Catheter Mapping of Spontaneous and Induced Atrial Fibrillation in Man Sanjeev SaksenaAmit ShankarRyszard B. Krol OriginalPaper Pages: 21 - 28
Atrial Fibrillation: Role of Arrhythmogenic Foci Pierre JaïsDipen C. ShahJacques Clémenty OriginalPaper Pages: 29 - 37
The MUSTT Study: Evaluating Testing and Treatment Helmut U. KleinSven Reek OriginalPaper Pages: 45 - 50
Amiodarone: Maximising Survival Benefit with Empiric or Guided Therapy G. SteinbeckU. DorwarthE. Hoffmann OriginalPaper Pages: 51 - 55
The Role of EP-Guided Therapy in Ventricular Arrhythmias: Beta-Blockers, Sotalol, and ICD's Alessandro CapucciDaniela AschieriGiovanni Quinto Villani OriginalPaper Pages: 57 - 63
Combining Antiarrhythmic Drugs and Implantable Devices Therapy: Benefits and Outcome Massimo SantiniClaudio PandoziRenato Ricci OriginalPaper Pages: 65 - 68
Lessons Learnt from Multisite Pacing for AF Management—Technical Challenges Rahul MehraBill KaemmererStephanie Fitts OriginalPaper Pages: 69 - 79
Electrophysiologic Assessment in Selecting Patients for Multisite Atrial Pacing Philippe DelfautSanjeev Saksena OriginalPaper Pages: 81 - 85
Developing Clinical Indication for Multisite Pacing L. KappenbergerX. LyonJ. Schlaepfer OriginalPaper Pages: 87 - 93
The Interpretation and Clinical Application of Data from Trials on Sudden Cardiac Death Robert J. MyerburgRaul MitraniAgustin Castellanos OriginalPaper Pages: 95 - 102
Evaluating AVID, CASH, CIDS, CABG-Patch & MADIT: Are They Concordant? Dirk BöckerGünter Breithardt OriginalPaper Pages: 103 - 108
Other Primary Prevention Trials—What Is Clinically And Economically Necessary? David S. Cannom OriginalPaper Pages: 109 - 115
New Mapping Technology for Atrial Tachycardias Ellen HoffmannPetra NimmermannGerhard Steinbeck OriginalPaper Pages: 117 - 120
Predictors of Success in Radiofrequency Catheter Ablation of Atrial Flutter Burghard SchumacherChristian WolpertBerndt Lüderitz OriginalPaper Pages: 121 - 125
Novel Catheter Technology for Ablative Cure of Atrial Fibrillation Michael D. LeshPeter GuerraKevin Taylor OriginalPaper Pages: 127 - 139
Atrial Fibrillation: Defining Potential Curative Ablation Targets David G. BendittNemer SamniahScott Sakaguchi OriginalPaper Pages: 141 - 147
Atrial Pacing to Prevent Atrial Fibrillation? S. Mark SopherA. John Camm OriginalPaper Pages: 149 - 153
New Devices and Hybrid Therapies and New Devices for Treatment of Atrial Fibrillation Ryszard B. KrolSanjeev SaksenaAtul Prakash OriginalPaper Pages: 163 - 169
The AFFIRM Trial: Main Trial and Substudies—What Can We Expect? D. George Wyse OriginalPaper Pages: 171 - 176
Pacing in Prevention of Atrial Fibrillation: The PIPAF Studies Frédéric AnselmeNadir SaoudiAlain Cribier OriginalPaper Pages: 177 - 184
Clinical Experience with Implantable Atrial and Combined Atrioventricular Defibrillators Werner JungChristian WolpertBerndt Lüderitz OriginalPaper Pages: 185 - 195
Design and Preliminary Data of the Metrix™ Atrioverter Expanded Indication Trial Carl TimmermansLuz-Maria RodriguezHein JJ Wellens OriginalPaper Pages: 197 - 199